MedTrace Logo

Prospective Multicenter Observational Study on the Use of NEOCEMENT® for the Treatment of Bone Defects

NCT05676905 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2025-01-31

No results posted yet for this study

Summary

Neocement is a CE marked device, registered in INFARMED (Portuguese National Competent Authority) and Department of Planning and Organisation of the National Health Service - General board of Medical Devices, pharmaceutical services, and safety in healthcare (Italy). This protocol does not include any new intended uses, new populations, new materials or design changes.

Conditions

  • Bone Deformity

Interventions

DEVICE

Neocement

Bone graft substitutes

Sponsors & Collaborators

  • European Clinical Research Infrastructure Network

    collaborator OTHER

  • Horizon 2020 - European Commission

    collaborator OTHER

  • Bioceramed

    lead INDUSTRY

Principal Investigators

  • Nuno Ribeiro, M. Doctor · Hospital Lusíadas Lisboa

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-06
Primary Completion
2024-11-06
Completion
2024-11-06

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05676905 on ClinicalTrials.gov